Physician profile
Rachel M Holley
NPI 1689126617
$2,046.64
in general payments reported to CMS, 2019-2025
17 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $246 · 2022: $653 · 2023: $313 · 2024: $411 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056 · Education: $90.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.11 |
| Education | $90.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $401.78 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $333.84 | 2021-2025 | |
| Amgen INC. | $321.37 | 2021-2025 | Otezla, Otezla, Enbrel |
| Sun Pharmaceutical Industries INC. | $273.41 | 2021-2024 | Ilumya |
| Janssen Biotech, INC. | $226.15 | 2021-2025 | Tremfya, Simponi Aria, Stelara |
| Genzyme Corporation | $157.44 | 2023-2025 | |
| Organon LLC | $42.00 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $40.72 | 2021-2022 | |
| Incyte Corporation | $35.90 | 2022 | |
| Dermavant Sciences, INC. | $34.19 | 2023-2024 | Vtama |
| Pfizer INC. | $33.53 | 2021-2022 | |
| Lilly USA, LLC | $32.63 | 2023 | Taltz, Olumiant |
| Mayne Pharma Commercial LLC | $30.26 | 2021-2022 | |
| Verrica Pharmaceuticals INC. | $23.18 | 2024 | Ycanth |
| Almirall LLC | $22.43 | 2025 | Klisyri |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $22.07 | 2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $15.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Holley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.